Be Well Clinical Studies

What Be Well Clinical Studies does

Be Well Clinical Studies is a privately held clinical research site organization founded in 2018 and operated as part of the Be Well Health collaborative alliance alongside sister companies Be Well MD (in-home concierge medical practice for older adults) and Be Well Memory and Infusion (cognitive care and infusion therapies). The company operates two principal sites — the original Round Rock, Texas location (established 2018) and the Lincoln, Nebraska location (established 2020) — with an additional Omaha, Nebraska office, collectively providing Midwest and South geographic coverage. Its core service is conducting Phase II through IV clinical trials for pharmaceutical, biotechnology, and medical research sponsors, with therapeutic-area specialization in geriatric and senior-relevant conditions including Alzheimer's disease, vaccines, diabetes, heart failure, obesity, and gout.

The company's operating infrastructure includes exam rooms, on-site labs, dedicated pharmacy, refrigeration, freezers, refrigerated centrifuge, and locking drug storage, along with dedicated monitor space. It supports infusion therapies and vaccine studies, and operates under NIH Office of Science Policy oversight via its Institutional Biosafety Committee arrangement with Sabai IBC, enabling protocols that involve recombinant or synthetic nucleic acid molecules. The founder and director, Dr. Mark Carlson, is a fellowship-trained board-certified geriatrician, internist, and oncologist with over 30 years of healthcare experience and a track record as principal investigator on more than 60 clinical trials; the broader team carries 100+ years of combined research experience with a long history of collaboration. Each site maintains 2 Principal Investigators and 3 Sub-Investigators.

Revenue is generated under a professional-services model through per-subject fees, study management fees, and pass-through costs paid by trial sponsors. Named enterprise sponsors include GSK (for which the site contributed to RSV vaccine research leading to the first FDA-approved RSV vaccine), Pfizer, Bristol Myers Squibb, Amgen, and Life Molecular Imaging. Volunteer recruitment is driven through a dedicated website, a Refer-a-Friend program offering $100 per enrolled patient, virtual educational events hosted by Dr. Carlson, and outreach to a network of senior living communities (55+ apartments, independent living, and assisted living facilities). Volunteer compensation is per visit, loaded onto a card within 5 business days, with IRS Form 1099 issued for annual stipends exceeding $600.

Name

Be Well Clinical Studies

Legal name

Be Well Clinical Studies

Website

https://bewellclinicalstudies.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Be Well Clinical Studies is a private clinical research site organization operating in Nebraska and Texas, conducting Phase II–IV trials for pharma and biotech sponsors with a geriatric specialization and senior-living-community patient access network.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical research site services
• Phase II-IV clinical trials
• Vaccine clinical trials
• Alzheimer's disease research
• Geriatric clinical research

Headquarters

HQ city

Lincoln

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Conduct Services: The company generates revenue by conducting clinical trials for pharmaceutical and biotechnology sponsors. They provide site facilities, recruit and manage study volunteers, collect data, and administer experimental treatments. Revenue is derived from per-subject fees, study management fees, and pass-through costs from sponsors.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Be Well Clinical Studies operates as a clinical research site conducting Phase II-IV clinical trials for pharmaceutical and biotechnology sponsors. The company recruits study volunteers, administers experimental treatments including infusions and vaccines, collects clinical data, and provides on-site lab, pharmacy, and monitoring capabilities across therapeutic areas such as Alzheimer's disease, vaccines, diabetes, heart failure, obesity, and gout.

Product overview

Be Well Clinical Studies is a clinical research organization operating as part of Be Well Health. The company provides a unified platform for clinical research trial services, connecting trial sponsors with volunteer participants. Their core offering consists of Clinical Research Trial Services (Phase II-IV trials), a Current Clinical Studies Platform listing active trials across multiple therapeutic areas (RSV, gout, obesity, Alzheimer's disease, diabetes, heart failure, vaccines, diabetic neuropathy), and Volunteer Recruitment Services for study participation. The company operates two research sites in the Midwest (Lincoln and Omaha, Nebraska) and South (Round Rock, Texas), serving trial sponsors with expertise in adult general medicine and geriatric care.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Trial Services
• Volunteer Recruitment Services
• Current Clinical Studies Platform
• Trial Sponsorship Services

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core, supporting and minor.

• Be Well HealthcoreStrategic or Co-development PartnerBe Well Clinical Studies is part of Be Well Health, a collaborative alliance dedicated to life-long health and wellness. This parent organization encompasses Be Well MD (in-home concierge medical practice), Be Well Clinical Studies (clinical trials for seniors), and Be Well Memory and Infusion (cognitive care and infusion therapies).
• Be Well MDcoreStrategic or Co-development PartnerSister company; first to launch as an in-home concierge medical practice designed for older adults. Be Well MD provides medical care while Be Well Clinical Studies focuses on research trials for seniors.
• Be Well Memory and InfusionsupportingStrategic or Co-development PartnerSister company providing specialized cognitive care and infusion therapies, complementing the clinical research services of Be Well Clinical Studies.
• Sabai IBCsupportingImplementation/ SI/ Consulting PartnerInstitutional Biosafety Committee services provider. Sabai IBC provides meeting minutes from convened IBC meetings conducted on behalf of the institution as required by NIH guidelines for research involving recombinant or synthetic nucleic acid molecules.
• NIH Office of Science PolicycoreOthersBe Well Clinical Studies operates under NIH oversight as a registered site for Institutional Biosafety Committees (IBCs) conducting research involving recombinant or synthetic nucleic acid molecules.
• Civitas Senior LivingminorGTM or Marketing PartnerDr. Carlson was invited by Civitas Senior Living to share insights about influences of technology on senior health in their Civitas Speaker Series Chat.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Syneos Health: Global CRO with site network and patient recruitment capabilities. Comparable as a larger incumbent offering integrated clinical development and site services to pharma sponsors.
• WCG: Provider of clinical research services including IRB, technology, and site support solutions. Comparable as a broader incumbent enabling and supporting clinical trial site operations across sponsors.
• IQVIA: Largest global CRO with a substantial site management organization (IQVIA Site Solutions). Overlaps with Be Well as a broader incumbent offering end-to-end clinical development services including site operations.
• Clinipace Worldwide: Mid-size global CRO offering clinical trial management and site support. Comparable as a broader incumbent in the same clinical development services category.
• Medpace: Mid-to-large global CRO with dedicated clinical trial infrastructure and site coordination. Comparable as a broader incumbent competing for the same Phase II-IV sponsor business.
• ICON plc: Global CRO formed via major consolidations (including PRA Health Sciences). Comparable as a broad incumbent with extensive site relationships and trial management capabilities.

Direct peers

• Elligo Health Research: Tech-enabled clinical research site network providing access to patients through existing physician relationships. Comparable as a site-network competitor pursuing decentralized and community-based trial models.
• Flourish Research: Multi-therapeutic clinical research site network formed via roll-up of independent sites. Directly comparable business model and serves the same sponsor base for Phase II-IV studies.
• Velocity Clinical Research: Multi-site clinical research site network operating dedicated research facilities across the US. Strongly comparable as a directly competing independent site network performing Phase II-IV trials for pharmaceutical sponsors.
• Accel Clinical Research: Privately held multi-site clinical research site organization. Comparable as a competing independent site network serving Phase II-IV trials across multiple therapeutic areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?t=15s&v=y6QAVmBJa3Y
• LinkedInlinkedin.com/company/be-well-clinical-studies

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Be Well Clinical Studies